<SEC-DOCUMENT>0001193125-23-149905.txt : 20230522
<SEC-HEADER>0001193125-23-149905.hdr.sgml : 20230522
<ACCEPTANCE-DATETIME>20230522074601
ACCESSION NUMBER:		0001193125-23-149905
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20230519
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230522
DATE AS OF CHANGE:		20230522

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Viatris Inc
		CENTRAL INDEX KEY:			0001792044
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				834364296
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39695
		FILM NUMBER:		23942453

	BUSINESS ADDRESS:	
		STREET 1:		1000 MYLAN BOULEVARD
		CITY:			CANONSBURG
		STATE:			PA
		ZIP:			15317
		BUSINESS PHONE:		(724) 514-1465

	MAIL ADDRESS:	
		STREET 1:		1000 MYLAN BOULEVARD
		CITY:			CANONSBURG
		STATE:			PA
		ZIP:			15317

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Upjohn Inc
		DATE OF NAME CHANGE:	20191023
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d475862d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:vtrs="http://www.viatris.com/20230519" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2023-05-19_to_2023-05-19">Viatris Inc</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2023-05-19_to_2023-05-19">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2023-05-19_to_2023-05-19">0001792044</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="vtrs-20230519.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-05-19_to_2023-05-19"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001792044</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-05-19</xbrli:startDate> <xbrli:endDate>2023-05-19</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-05-19_to_2023-05-19">8-K</ix:nonNumeric></span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-05-19_to_2023-05-19" format="ixt:datemonthdayyearen">May&#160;19, 2023</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">VIATRIS INC.</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2023-05-19_to_2023-05-19" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2023-05-19_to_2023-05-19">001-39695</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2023-05-19_to_2023-05-19">83-4364296</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of Incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(I.R.S. Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2023-05-19_to_2023-05-19">1000 Mylan Boulevard</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2023-05-19_to_2023-05-19">Canonsburg</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2023-05-19_to_2023-05-19" format="ixt-sec:stateprovnameen">Pennsylvania</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2023-05-19_to_2023-05-19">15317</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of Principal Executive Offices)</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2023-05-19_to_2023-05-19">(724)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2023-05-19_to_2023-05-19">514-1800</ix:nonNumeric></span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2023-05-19_to_2023-05-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2023-05-19_to_2023-05-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2023-05-19_to_2023-05-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2</span> (b))</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2023-05-19_to_2023-05-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4</span> (c))</p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-05-19_to_2023-05-19">Common Stock, par value $0.01 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-05-19_to_2023-05-19">VTRS</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-05-19_to_2023-05-19" format="ixt-sec:exchnameen">The NASDAQ Stock Market</ix:nonNumeric></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2023-05-19_to_2023-05-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Executive Chairman Transition </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On May&#160;19, 2023, Robert J. Coury, the Executive Chairman of Viatris Inc. (the &#8220;Company&#8221; or &#8220;Viatris&#8221;), agreed with the independent members of the Board of Directors (the &#8220;Board&#8221;) to transition to a new role as Chairman Emeritus and Senior Strategic Advisor from the conclusion of the Company&#8217;s 2023 Annual Meeting of Shareholders (the &#8220;2023 Annual Meeting&#8221;) through the end of 2025 (the same period that Mr.&#160;Coury previously committed to the Company under his Executive Employment Agreement when Viatris was created). As a result of Mr.&#160;Coury&#8217;s agreement to serve in this advisory role, the independent members of the Board and Mr.&#160;Coury agreed that Mr.&#160;Coury will not stand for <span style="white-space:nowrap">re-election</span> at the 2023 Annual Meeting and will cease to be a director and to serve as an officer and employee of the Company effective as of the conclusion of the 2023 Annual Meeting. The Board will select a new independent chair of the Board who will be announced in the coming months and whose tenure is intended to begin following the 2023 Annual Meeting. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In connection with this transition, Mr.&#160;Coury will be treated as separating from employment for Good Reason for severance benefit purposes (as defined in, and pursuant to, his Executive Employment Agreement). The Company will also honor the existing compensation rights set forth in that agreement for 2024 and 2025 through an annual consulting fee of $15&#160;million, paid in monthly installments. The Board believes and anticipates that the value of the compensation is commensurate with the value and benefits to be received by the Company from Mr.&#160;Coury&#8217;s advisory services. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Mr.&#160;Coury previously served in various roles for Mylan, including as Chief Executive Officer and Executive Chairman, since 2002. Mr.&#160;Coury grew Mylan from the third-largest generics pharmaceutical company in the United States to one of the largest, strongest and most well-diversified and respected pharmaceutical companies in the world, laying the strong foundation for the Company as it stands today. Mr.&#160;Coury, in the final stages of the <span style="white-space:nowrap">build-out</span> phase of Mylan&#8217;s strategic plan, also played an instrumental and pivotal role in identifying and consummating the combination of Mylan with Pfizer Inc.&#8217;s Upjohn business to form Viatris on November&#160;16, 2020. Mr.&#160;Coury has led the Company&#8217;s strategy on highly complex matters and other strategic initiatives including significant mergers and acquisitions, among other matters. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Mr.&#160;Coury&#8217;s transition as described herein is in no way the result of any disagreement between Mr.&#160;Coury and the Company on any matter relating to the Company&#8217;s operations, policies, or practices. The Board, Mr.&#160;Coury and Mr.&#160;Smith, the Company&#8217;s recently-appointed Chief Executive Officer, are committed to continuing to collaborate on the execution of the Company&#8217;s strategic plans. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Director Appointment </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On May&#160;19, 2023, the Board appointed Leo Groothuis as an independent (as defined in the applicable NASDAQ listing rules) member of the Board, effective immediately. Mr.&#160;Groothuis is a Class&#160;I director, with a term of office expiring at the 2023 Annual Meeting. The Board anticipates naming Mr.&#160;Groothuis to serve on one or more committees of the Board, but at the time of this Current Report on <span style="white-space:nowrap">Form&#160;8-K,&#160;has</span> not determined the committee(s) to which Mr.&#160;Groothuis will be named. The Company will file an amendment to this Current Report on <span style="white-space:nowrap">Form&#160;8-K&#160;naming</span> those committees once they are determined. The Company has entered into an indemnification agreement with Mr.&#160;Groothuis, the form of which appears as Exhibit 10.25 to the Company&#8217;s Annual Report on <span style="white-space:nowrap">Form&#160;10-K&#160;for</span> the fiscal year ended December&#160;31, 2020. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">There are no arrangements or understandings between Mr.&#160;Groothuis and any other persons pursuant to which he was selected as a director and Mr.&#160;Groothuis has no direct or indirect material interest in any transaction requiring disclosure under Item 404(a) of <span style="white-space:nowrap">Regulation&#160;S-K.</span> </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;7.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Regulation FD Disclosure. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On May&#160;22, 2023, the Company issued press releases announcing the Executive Chairman transition and the appointment of Mr.&#160;Groothuis.&#160;A copy of each press release is attached hereto as Exhibit 99.1 and Exhibit 99.2, respectively, and is incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The information in this Item 7.01 (including Exhibits 99.1 and 99.2) shall not be deemed to be &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Forward-Looking Statements </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">This Current Report on <span style="white-space:nowrap">Form&#160;8-K</span> contains &#8220;forward-looking statements&#8221;. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may include, without limitation, statements regarding the Executive Chairman transition and director appointment; that as a result of Mr.&#160;Coury&#8217;s agreement to serve in his advisory role, the independent members of the Board and Mr.&#160;Coury agreed that Mr.&#160;Coury will not stand for <span style="white-space:nowrap">re-election</span> at the 2023 Annual Meeting and will cease to be a director and to serve as an officer and employee of the Company effective as of the conclusion of the 2023 Annual Meeting; that the Board will select a new independent chair of the Board who will be announced in the coming months and whose tenure is intended to begin following the 2023 Annual Meeting; that in connection with this transition, Mr.&#160;Coury will be treated as separating from employment for Good Reason for severance benefit purposes (as defined in, and pursuant to, his Executive Employment Agreement); that the Company will also honor the existing compensation rights set forth in that agreement for 2024 and 2025 through an annual consulting fee of $15&#160;million, paid in monthly installments; that the Board believes and anticipates that the value of the compensation is commensurate with the value and benefits to be received by the Company from Mr.&#160;Coury&#8217;s advisory services; that the Board, Mr.&#160;Coury and Mr.&#160;Smith, the Company&#8217;s recently-appointed Chief Executive Officer, are committed to continuing to collaborate on the execution of the Company&#8217;s strategic plans; the Board anticipates naming Mr.&#160;Groothuis to serve on one or more committees of the Board, but at the time of this Current Report on <span style="white-space:nowrap">Form&#160;8-K,</span> has not determined the committee(s) to which Mr.&#160;Groothuis will be named; and that the Company will file an amendment to this Current Report on Form <span style="white-space:nowrap">8-K</span> naming those committees once they are determined. Forward-looking statements may often be identified by the use of words such as &#8220;will&#8221;, &#8220;may&#8221;, &#8220;could&#8221;, &#8220;should&#8221;, &#8220;would&#8221;, &#8220;project&#8221;, &#8220;believe&#8221;, &#8220;anticipate&#8221;, &#8220;expect&#8221;, &#8220;plan&#8221;, &#8220;estimate&#8221;, &#8220;forecast&#8221;, &#8220;potential&#8221;, &#8220;pipeline&#8221;, &#8220;intend&#8221;, &#8220;continue&#8221;, &#8220;target&#8221;, &#8220;seek&#8221; and variations of these words or comparable words. Because forward-looking statements inherently involve risks and uncertainties, actual future results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: the possibility that the Company may be unable to realize the intended benefits of, or achieve the intended goals or outlooks with respect to, its strategic initiatives; the possibility that the Company may be unable to achieve expected benefits, synergies and operating efficiencies in connection with acquisitions, divestitures, or its global restructuring program, within the expected timeframe or at all; impairment charges or other losses related to the divestiture or sale of businesses or assets; the Company&#8217;s failure to achieve expected or targeted future financial and operating performance and results; the potential impact of public health outbreaks, epidemics and pandemics, including the ongoing challenges and uncertainties posed by the <span style="white-space:nowrap">COVID-19</span> pandemic; actions and decisions of healthcare and pharmaceutical regulators; changes in relevant laws and regulations, including but not limited to changes in tax, healthcare and pharmaceutical laws and regulations globally (including the impact of recent and potential tax reform in the U.S.); the ability to attract and retain key personnel; the Company&#8217;s liquidity, capital resources and ability to obtain financing; any regulatory, legal or other impediments to the Company&#8217;s ability to bring new products to market, including but not limited to <span style="white-space:nowrap">&#8220;at-risk</span> launches&#8221;; success of clinical trials and the Company&#8217;s or its partners&#8217; ability to execute on new product opportunities and develop, manufacture and commercialize products; any changes in or difficulties with the Company&#8217;s manufacturing facilities, including with respect to inspections, remediation and restructuring activities, supply chain or inventory or the ability to meet anticipated demand; the scope, timing and outcome of any ongoing legal proceedings, including government inquiries or investigations, and the impact of any such proceedings on the Company; any significant breach of data security or data privacy or disruptions to our information technology systems; risks associated with having significant operations globally; the ability to protect intellectual property and preserve intellectual property rights; changes in third-party relationships; the effect of any changes in the Company&#8217;s or its partners&#8217; customer and supplier relationships and customer purchasing patterns, including customer loss and business disruption being greater than expected following an acquisition or divestiture; the impacts of competition, including decreases in sales or revenues as a result of the loss of market exclusivity for certain products; changes in the economic and financial conditions of the Company or its partners; uncertainties regarding future demand, pricing and reimbursement for the Company&#8217;s products; uncertainties and matters beyond the control of management, including but not limited to general political and economic conditions, inflation rates and global exchange rates; and inherent uncertainties involved in the estimates and judgments used in the preparation of financial statements, and the providing of estimates of financial measures, in accordance with accounting principles generally accepted in the United States and related standards or on an adjusted basis. For more detailed information on the risks and uncertainties associated with Viatris, see the risks described in Part I, Item 1A of the Company&#8217;s Annual Report on Form <span style="white-space:nowrap">10-K</span> for the year ended December&#160;31, 2022, as amended, and our other filings with the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;). You can access Viatris&#8217; filings with the SEC through the SEC website at www.sec.gov or through our website, and Viatris strongly encourages you to do so. Viatris routinely posts information that may be important to investors on our website at investor.viatris.com, and we use this website address as a means of disclosing material information to the public in a broad, <span style="white-space:nowrap">non-exclusionary</span> manner for purposes of the SEC&#8217;s Regulation Fair Disclosure (Reg FD). The contents of our website are not incorporated into this filing or our other filings with the SEC. Viatris undertakes no obligation to update any statements herein for revisions or changes after the date of this filing other than as required by law. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d)&#160;&#160;&#160;&#160;Exhibits. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"><span style="font-weight:bold">Exhibit<br />No.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Description</span></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d475862dex991.htm">Executive Chairman Transition Press Release, dated May&#160;22, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d475862dex992.htm">Director Appointment Press Release, dated May&#160;22, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.</td></tr>
</table> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3">VIATRIS INC.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: May&#160;22, 2023</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Sanjeev Narula</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Sanjeev Narula</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Chief Financial Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d475862dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g475862g0520052105445.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Robert J. Coury to Transition from Executive Chairman of Viatris to Chairman Emeritus and Senior
Strategic Advisor to the Board and Management at the End of the Year </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Coury will serve in this new role until the end
of 2025 </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Pittsburgh &#150; May</B><B></B><B>&nbsp;22, 2023 &#150;</B> <U>Viatris Inc</U>. (NASDAQ: VTRS), a global healthcare company, announced
today that as a result of the strength and stability that Viatris has achieved since its formation in 2020, including its ninth consecutive quarter of solid execution and performance, as well as the successful completion of the integration of its
two legacy companies, <U>Robert J. Coury</U>, the key architect behind Viatris&#146; unique and powerful global platform, will once again transition his role, this time from his current position of Executive Chairman to Chairman Emeritus and Senior
Strategic Advisor to the board and management following the company&#146;s 2023 annual meeting of shareholders. The annual meeting for 2023 is anticipated to occur in <FONT STYLE="white-space:nowrap">mid-December</FONT> of this year, at which time
Mr.&nbsp;Coury will not be standing for <FONT STYLE="white-space:nowrap">re-election.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Given his longstanding and critical connection to, as well
as direct oversight of, many of Viatris&#146; significant ongoing business matters and strategic development opportunities, Coury will continue to serve the company in this new <FONT STYLE="white-space:nowrap">non-employee,</FONT> strategic advisor
capacity until the end of 2025 when the term of his contract would have otherwise expired. This will not only ensure a smooth transition but also help limit potential business or strategic disruptions. The Viatris board will select a new independent
chair of the board who will be announced in the coming months and whose tenure is intended to begin following the 2023 annual meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Robert J. Coury
said, &#147;Given the success and stability of Viatris to date and the sustainable future I see ahead for the company as we near the completion of our Phase 1 long-term strategic plan, I am very pleased to be in a position to plan a clear and
orderly transition for the company. This will provide an opportunity for its leaders to further progress and grow, while I also remain available to continue to advise the board and management on ongoing matters and help ensure the success of the
company&#146;s long-term goals. With Viatris&#146; powerful foundation now securely in place, with Scott A. Smith at the helm as our new CEO, and with the clear and defined path that we established for growth going forward, I have never been more
confident in the future of our company, our employees and all of our stakeholders than I am today.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Coury concluded, &#147;I have had the great
fortune and opportunity over time to work with many leadership teams and board members in addition to Scott and our current members of the board, as we have successfully set and then executed against our long-term vision and our mission of access. I
want to sincerely thank each and every one of them for their commitment and partnership. However, it is really the employees of Viatris, including all those who came during my time with Mylan and those who joined the company just a few short years
ago from Upjohn, who have done the real work to turn our strategic vision and mission into a reality. Time after time, each and every one of them has stepped up whenever called upon to do whatever it took to get the job done. It has been, and will
always be, my true privilege to serve them.&#148; </P> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g475862g0520052105445.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Viatris Lead Independent Director, Mark Parrish said, &#147;Throughout my entire time working with Robert, I
have found him to be a true visionary who has worked tirelessly for more than two decades overseeing the execution of his vision to build Mylan and now Viatris into one of the most powerful global platforms in our industry today. He has truly been
the key architect behind the company&#146;s constant pursuit and achievement of unmatched global access and scale across our manufacturing, R&amp;D, product portfolio, and geographic footprint, all while maintaining one of the strongest balance
sheets within our sector. His foresight also led to the creation of what is known as the company&#146;s Global Healthcare Gateway, a unique asset that can provide an entry point for any other pharmaceutical company within the industry that has the
desire to leverage Viatris&#146; <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-of-a-kind</FONT></FONT></FONT> global footprint. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Added Parrish, &#147;In an industry that is incredibly fast-paced and ever evolving, the board is unanimous in its belief that Robert&#146;s trademark
combination of vision, passion and long-term strategic thinking has positioned Viatris as one of the strongest companies within our industry segment and further sets the stage for the sustainable future we see for the company, as we continue to grow
and move up the pharmaceutical value chain. Thanks to Robert&#146;s oversight, and with Phase 1 of our strategic plan nearly complete and a clear path set for Phase 2, we find our company extremely well-positioned and with a defined mission of
providing global patient access and a commitment to its pursuit that we believe will be long-lasting.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Parrish concluded, &#147;Another one of
Robert&#146;s most important responsibilities was his mentoring of management, and we are pleased that he has agreed to continue to perform this role and remain available to them and to the board whenever needed as Chairman Emeritus and Senior
Strategic Advisor. On behalf of every member of the board, past and present, we cannot thank Robert enough for all that he has done to position the company for this moment, and for the long-term success we see ahead.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Viatris CEO, <U>Scott A. Smith</U> commented, &#147;From the first day that I had the opportunity to meet Robert when initially discussing the opportunity to
join the Viatris board, I couldn&#146;t help but be struck by his incredible energy, engagement, passion and love for the company and its people. My appreciation for his intense commitment and knowledge only deepened as I saw him in action leading
the board, helping support the management team, and interacting with our internal teams and external partners around the globe. Robert has a deeply strategic mindset and vast industry and business expertise, but as importantly, it is clear to me as
both a board member and as CEO that he commands the genuine respect of all those who work with him and around him. I consider him one of the strongest leaders in the industry, and I am grateful that he will remain available to advise me and the
board on many ongoing business matters and other strategic development activities. I cannot thank him enough for his support and guidance over the past several months and know he will continue to be an invaluable resource as I take the torch that he
has passed to me as CEO and we move the company into its next phase of opportunity and growth.&#148; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g475862g0520052105445.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About&nbsp;Viatris </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Viatris Inc.&nbsp;(NASDAQ: VTRS) is a global healthcare company empowering people worldwide to live healthier at every stage of life. We provide access to
medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">one-of-a-kind</FONT></FONT></FONT> Global Healthcare Gateway<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>. Formed in November 2020, Viatris brings together scientific, manufacturing and distribution expertise
with proven regulatory, medical, and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris&#146; portfolio comprises more than 1,400 approved molecules across a wide range of
therapeutic areas, spanning both <FONT STYLE="white-space:nowrap">non-communicable</FONT> and infectious diseases, including globally recognized brands, complex generic and branded medicines and a variety of <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">over-the-counter</FONT></FONT> consumer products. With more than 38,000 colleagues globally, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com
and investor.viatris.com, and connect with us on <U>Twitter</U>, LinkedIn, Instagram and YouTube.</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-looking Statements</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release includes statements that constitute &#147;forward-looking statements.&#148; These statements are made pursuant to the safe harbor provisions
of the Private Securities Litigation Reform Act of 1995. Such forward looking statements may include statements that Robert J. Coury, the key architect behind Viatris&#146; unique and powerful global platform, will once again transition his role,
this time from his current position of Executive Chairman to Chairman Emeritus and Senior Strategic Advisor to the board and management following the company&#146;s 2023 annual meeting of shareholders; the annual meeting for 2023 is anticipated to
occur in <FONT STYLE="white-space:nowrap">mid-December</FONT> of this year, at which time Mr.&nbsp;Coury will not be standing for <FONT STYLE="white-space:nowrap">re-election;</FONT> given his longstanding and critical connection to, as well as
direct oversight of, many of Viatris&#146; significant ongoing business matters and strategic development opportunities, Coury will continue to serve the company in this new <FONT STYLE="white-space:nowrap">non-employee</FONT> strategic advisor
capacity until the end of 2025 when the term of his contract would have otherwise expired; this will not only ensure a smooth transition but also help limit potential business or strategic disruptions; the Viatris board will select a new independent
chair of the board who will be announced in the coming months and whose tenure is intended to begin following the 2023 annual meeting; given the success and stability of Viatris to date and the sustainable future I see ahead for the company as we
near the completion of our Phase 1 long-term strategic plan, I am very pleased to be in a position to plan a clear and orderly transition for the company; this will provide an opportunity for its leaders to further progress and grow, while I remain
available to continue to advise the board and management on ongoing matters and help ensure the success of the company&#146;s long-term goals; with Viatris&#146; powerful foundation now securely in place, with Scott A. Smith at the helm as our new
CEO, and with the clear and defined path that we established for growth going forward, I have never been more confident in the future of our company, our employees and all of our stakeholders than I am today; his foresight also
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g475862g0520052105445.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
led to the creation of what is known as the company&#146;s Global Healthcare Gateway, a unique asset that can provide an entry point for any other pharmaceutical company within the industry that
has the desire to leverage Viatris&#146; <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-of-a-kind</FONT></FONT></FONT> global footprint; in an industry that is incredibly fast-paced and ever
evolving, the board is unanimous in its belief that Robert&#146;s trademark combination of vision, passion and long-term strategic thinking has positioned Viatris as one of the strongest companies within our industry segment and further sets the
stage for the sustainable future we see for the company as we continue to grow and move up the pharmaceutical value chain; thanks to Robert&#146;s oversight, and with Phase 1 of our strategic plan nearly complete and a clear path set for Phase 2, we
find our company extremely well-positioned and with a defined mission of providing global patient access and a commitment to its pursuit that we believe will be long-lasting; another one of Robert&#146;s most important responsibilities was his
mentoring of management, and we are pleased that he has agreed to continue to perform this role and remain available to them and to the board whenever needed as Chairman Emeritus and Senior Strategic Advisor; on behalf of every member of the board,
past and present, we cannot thank Robert enough for all that he has done to position the company for this moment, and for the long-term success we see ahead; and I cannot thank him enough for his support and guidance over the past several months and
know he will continue to be an invaluable resource as I take the torch that he has passed to me as CEO and we move the company into its next phase of opportunity and growth. Factors that could cause or contribute to such differences include, but are
not limited to: the possibility that the Company may be unable to realize the intended benefits of, or achieve the intended goals or outlooks with respect to, its strategic initiatives; the possibility that the Company may be unable to achieve
expected benefits, synergies and operating efficiencies in connection with acquisitions, divestitures, or its global restructuring program, within the expected timeframe or at all; impairment charges or other losses related to the divestiture or
sale of businesses or assets; the Company&#146;s failure to achieve expected or targeted future financial and operating performance and results; the potential impact of public health outbreaks, epidemics and pandemics, including the ongoing
challenges and uncertainties posed by <FONT STYLE="white-space:nowrap">COVID-19;</FONT> actions and decisions of healthcare and pharmaceutical regulators; changes in healthcare and pharmaceutical laws and regulations in the U.S. and abroad; any
regulatory, legal or other impediments to Viatris&#146; ability to bring new products to market, including but not limited to <FONT STYLE="white-space:nowrap">&#147;at-risk&#148;</FONT> launches; Viatris&#146; or its partners&#146; ability to
develop, manufacture, and commercialize products; the scope, timing and outcome of any ongoing legal proceedings, and the impact of any such proceedings; any significant breach of data security or data privacy or disruptions to our information
technology systems; risks associated with international operations; the ability to protect intellectual property and preserve intellectual property rights; changes in third-party relationships; the effect of any changes in Viatris&#146; or its
partners&#146; customer and supplier relationships and customer purchasing patterns; the impacts of competition; changes in the economic and financial conditions of Viatris or its partners; uncertainties and matters beyond the control of management,
including general economic conditions, inflation and exchange rates; failure to execute stock repurchases consistent with current expectations; stock price volatility; and the other risks described in Viatris&#146; filings with the Securities and
Exchange Commission (SEC). Viatris routinely uses its website as a means of disclosing material information to the public in a broad, <FONT STYLE="white-space:nowrap">non-exclusionary</FONT> manner for purposes of the SEC&#146;s Regulation Fair
Disclosure (Reg FD). Viatris undertakes no obligation to update these statements for revisions or changes after the date of this release other than as required by law. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contacts: </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="67%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>MEDIA</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>INVESTORS</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">+1.724.514.1968</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">+1.412.707.2866</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>Communications@viatris.com</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>InvestorRelations@viatris.com</U></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Jennifer Mauer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Bill Szablewski</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>Jennifer.Mauer@viatris.com</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>William.Szablewski@viatris.com</U></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Matt Klein</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>Matthew.Klein@viatris.com</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B># # # </B></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>d475862dex992.htm
<DESCRIPTION>EX-99.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.2 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g475862g0520052519545.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Viatris Announces Appointment of Leo Groothuis to </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Company&#146;s Board of Directors </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PITTSBURGH &#150; May</B><B></B><B>&nbsp;22, 2023</B> &#150; <U>Viatris</U><U> Inc.</U> (NASDAQ: VTRS), a global healthcare company, today announced that
as part of its ongoing board refreshment efforts, Leo Groothuis has been appointed as Viatris&#146; newest member of its board of directors. Groothuis fills the vacancy created by the previous departure of Michael Goettler in April of this year.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Groothuis has significant international experience and serves as General Counsel of HAL Investments, the Dutch investment subsidiary of HAL Holding N.V.,
an international investment company listed on the Amsterdam stock exchange, which is focused on increasing shareholder value. In addition to his strategic, financial and governance focus, he has also been actively involved in the development and
execution of HAL Investments&#146; ESG strategy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Throughout his career, Groothuis has been a trusted <FONT STYLE="white-space:nowrap">C-suite</FONT> and
board advisor to some of the largest companies in both Europe and the U.S. Prior to his role at HAL Investments, he served as practice leader at NautaDutilh, an international law firm, where he guided numerous multi-national companies on significant
and complex transactions. As a result, he is recognized as a top lawyer and thought leader in corporate governance, capital markets and M&amp;A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Viatris
Executive Chairman Robert J. Coury said, &#147;We are extremely pleased to welcome Leo Groothuis, a recognized top international executive to the Viatris board. We believe his proven strategic, corporate governance and capital markets experience
should serve as a tremendous asset for Viatris, as we continue to look for ways to build and unlock value for our shareholders.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About&nbsp;Viatris </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Viatris Inc.&nbsp;(NASDAQ: VTRS) is a
global healthcare company empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people
to more products and services through our <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-of-a-kind</FONT></FONT></FONT> Global Healthcare
Gateway<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>. Formed in November 2020, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical, and commercial capabilities to deliver
high-quality medicines to patients in more than 165 countries and territories. Viatris&#146; portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both
<FONT STYLE="white-space:nowrap">non-communicable</FONT> and infectious diseases, including globally recognized brands, complex generic and branded medicines and a variety of
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> consumer products. With more than 38,000 colleagues globally, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai and
Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on <U>Twitter</U>, LinkedIn, Instagram and YouTube.</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g475862g0520052105445.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-looking Statements</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release includes statements that constitute &#147;forward-looking statements.&#148; These statements are made pursuant to the safe harbor provisions
of the Private Securities Litigation Reform Act of 1995. Such forward looking statements may include statements that we believe his proven strategic, corporate governance and capital markets experience should serve as a tremendous asset for Viatris,
as we continue to look for ways to build and unlock value for our shareholders. Factors that could cause or contribute to such differences include, but are not limited to: the possibility that the Company may be unable to realize the intended
benefits of, or achieve the intended goals or outlooks with respect to, its strategic initiatives; the possibility that the Company may be unable to achieve expected benefits, synergies and operating efficiencies in connection with acquisitions,
divestitures, or its global restructuring program, within the expected timeframe or at all; impairment charges or other losses related to the divestiture or sale of businesses or assets; the Company&#146;s failure to achieve expected or targeted
future financial and operating performance and results; the potential impact of public health outbreaks, epidemics and pandemics, including the ongoing challenges and uncertainties posed by <FONT STYLE="white-space:nowrap">COVID-19;</FONT> actions
and decisions of healthcare and pharmaceutical regulators; changes in healthcare and pharmaceutical laws and regulations in the U.S. and abroad; any regulatory, legal or other impediments to Viatris&#146; ability to bring new products to market,
including but not limited to <FONT STYLE="white-space:nowrap">&#147;at-risk&#148;</FONT> launches; Viatris&#146; or its partners&#146; ability to develop, manufacture, and commercialize products; the scope, timing and outcome of any ongoing legal
proceedings, and the impact of any such proceedings; any significant breach of data security or data privacy or disruptions to our information technology systems; risks associated with international operations; the ability to protect intellectual
property and preserve intellectual property rights; changes in third-party relationships; the effect of any changes in Viatris&#146; or its partners&#146; customer and supplier relationships and customer purchasing patterns; the impacts of
competition; changes in the economic and financial conditions of Viatris or its partners; uncertainties and matters beyond the control of management, including general economic conditions, inflation and exchange rates; failure to execute stock
repurchases consistent with current expectations; stock price volatility; and the other risks described in Viatris&#146; filings with the Securities and Exchange Commission (SEC). Viatris routinely uses its website as a means of disclosing material
information to the public in a broad, <FONT STYLE="white-space:nowrap">non-exclusionary</FONT> manner for purposes of the SEC&#146;s Regulation Fair Disclosure (Reg FD). Viatris undertakes no obligation to update these statements for revisions or
changes after the date of this release other than as required by law. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contacts:</B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>MEDIA</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>INVESTORS</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">+1.724.514.1968</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">+1.412.707.2866</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><U>Communications@viatris.com</U></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><U>InvestorRelations@viatris.com</U></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jennifer Mauer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bill Szablewski</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><U>Jennifer.Mauer@viatris.com</U></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><U>William.Szablewski@viatris.com</U></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matt Klein</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><U>Matthew.Klein@viatris.com</U></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B># # # </B></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>vtrs-20230519.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 5/22/2023 3:31:39 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2022"
  xmlns:vtrs="http://www.viatris.com/20230519"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.viatris.com/20230519"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vtrs-20230519_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vtrs-20230519_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.viatris.com//20230519/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>vtrs-20230519_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 5/22/2023 3:31:39 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>vtrs-20230519_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 5/22/2023 3:31:39 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.viatris.com//20230519/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="vtrs-20230519.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.viatris.com//20230519/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g475862g0520052105445.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g475862g0520052105445.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !+ +\# 2(  A$! Q$!_\0
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MM?ZC9:7:-=7]U#;6Z?>DE<*!^=<'?_&SPA9R%(9+R\P?O6\''YL15QIRE\*
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MY]$,],HKSSQOHWCZ^US[1X:UF.TT\0*#$TFT[P3DXVGMBO./"E_\2O&7VO\
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F444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g475862g0520052519545.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g475862g0520052519545.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !+ +\# 2(  A$! Q$!_\0
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MM?ZC9:7:-=7]U#;6Z?>DE<*!^=<'?_&SPA9R%(9+R\P?O6\''YL15QIRE\*
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MY]$,],HKSSQOHWCZ^US[1X:UF.TT\0*#$TFT[P3DXVGMBO./"E_\2O&7VO\
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F444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140545276791568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 19, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Viatris Inc<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001792044<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 19,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39695<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">83-4364296<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1000 Mylan Boulevard<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Canonsburg<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">PA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">15317<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(724)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">514-1800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">VTRS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>d475862d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="vtrs-20230519.xsd" xlink:type="simple"/>
    <context id="duration_2023-05-19_to_2023-05-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001792044</identifier>
        </entity>
        <period>
            <startDate>2023-05-19</startDate>
            <endDate>2023-05-19</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2023-05-19_to_2023-05-19"
      id="Hidden_dei_EntityRegistrantName">Viatris Inc</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2023-05-19_to_2023-05-19">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-05-19_to_2023-05-19"
      id="Hidden_dei_EntityCentralIndexKey">0001792044</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2023-05-19_to_2023-05-19">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-05-19_to_2023-05-19">2023-05-19</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2023-05-19_to_2023-05-19">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2023-05-19_to_2023-05-19">001-39695</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2023-05-19_to_2023-05-19">83-4364296</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-05-19_to_2023-05-19">1000 Mylan Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-05-19_to_2023-05-19">Canonsburg</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2023-05-19_to_2023-05-19">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-05-19_to_2023-05-19">15317</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2023-05-19_to_2023-05-19">(724)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-05-19_to_2023-05-19">514-1800</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2023-05-19_to_2023-05-19">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-05-19_to_2023-05-19">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-05-19_to_2023-05-19">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-05-19_to_2023-05-19">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2023-05-19_to_2023-05-19">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-05-19_to_2023-05-19">VTRS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-05-19_to_2023-05-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-05-19_to_2023-05-19">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M1S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ O3VV5I>*NQS
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M=1,92L88!.R '<(Y_<Z[5ITPX1X=\G>A^[<#K3P&]'@!6^A<JU3'\TLDO,3
MQFU+BLX5>C(,=D",Y1]XVXG\-/O4(VSV'T:$%'J6"V&%E+C?Z/F-:#R!+ ]=
MR_$)'0.M#,,SQ;;!<.AHQ$5V9://8:Q#B'/Z3XRQJK"$52Q;#X&'' E<)S"D
M&IND53 >"CVN*!.L>@PL(:EU&*ADMW,JI]=V<,TB]RI#FJ,,:&T'X:-:"Q4&
ML&]R( DNR94;4EWI>::W=Y-[2:AU[D&P]_ :C1W-CQ^W_ %02P,$%     @
MO3VV5B0>FZ*M    ^ $  !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L
M<[61/0Z#, R%KQ+E #50J4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>+7_O
MR4Z?:!1W;J"V\R1&:P;*9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!
MV#-DGNZ9HIP\_D-T==UI?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6
MHJ@R&8HJEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0
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M&G_FB^$_7G\!4$L! A0#%     @ O3VV5@=!36*!    L0   !
M     ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "]/;96)64[
M^>\    K @  $0              @ &O    9&]C4')O<',O8V]R92YX;6Q0
M2P$"% ,4    " "]/;96F5R<(Q &  "<)P  $P              @ '- 0
M>&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( +T]ME:A4U\30@0  (80
M   8              " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q0
M2P$"% ,4    " "]/;96GZ ;\+$"  #B#   #0              @ &&#
M>&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( +T]ME:7BKL<P    !,"   +
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4!08     "0 ) #X"  #F$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d475862d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.viatris.com//20230519/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName -  d475862d8k.htm 7</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" original="d475862d8k.htm">d475862d8k.htm</File>
    <File>d475862dex991.htm</File>
    <File>d475862dex992.htm</File>
    <File>vtrs-20230519.xsd</File>
    <File>vtrs-20230519_lab.xml</File>
    <File>vtrs-20230519_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d475862d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d475862d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "vtrs-20230519_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "vtrs-20230519_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "vtrs-20230519.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "vtrs",
   "nsuri": "http://www.viatris.com/20230519",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d475862d8k.htm",
      "contextRef": "duration_2023-05-19_to_2023-05-19",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.viatris.com//20230519/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d475862d8k.htm",
      "contextRef": "duration_2023-05-19_to_2023-05-19",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.viatris.com//20230519/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001193125-23-149905-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-149905-xbrl.zip
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MHS)MOY)^=QV[:?8V8+=_3-#DY5]EB!>&4FA&)(BEUN>X]W-UPN8?1JJ7]I_
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M:QI ?5 ,[(HIDG\5J0&NX M<V@=)T>Y\K"O-QS:*D-XI.;+0_@\U[?/3Z!-
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M,2A?L.?Y.7J>GZ^K9ULN7^187;G\TOAD26#QICE0X0RN0'P;'?X_4$L#!!0
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M B:'(DZ<Z]+6+15QDA3>RL;'5ZJ@0F[^H(;:RQ3'U 6[G66;27)+9D1_9AN
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MP^:9=+.$6'S6N0,J!8DD9F@$3U""-9;#%Q5/6Q2LB98V3#2R093 #MTD@T.
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MJ*/$S*Q,:^VS1I9CM/6*)K:]YOZFR?!19\:2T3,3*W\AE(B@!5U.[WD-$6%
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ME/1GO>MA[^Y/-I,^U4[Z_#;,]M;>[J?:,.D?/4E4\^[!>N/HRW7 B#D@-L]
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M%A<720TE=$[BD\UG:H3$7%"T6$GO&%RI -F2C C#@],1OE<NE<^=10K2])V
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M,#(S,#4Q.2YX<V102P$"% ,4    " "]/;96^NE'.6 &  "^0P  %0
M        @ &\1@  =G1R<RTR,#(S,#4Q.5]L86(N>&UL4$L! A0#%     @
MO3VV5F^4?C*U!   >BH  !4              ( !3TT  '9T<G,M,C R,S U
@,3E?<')E+GAM;%!+!08     !@ & '\!   W4@     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
